{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T12:17:53Z","timestamp":1697372273745},"reference-count":20,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T00:00:00Z","timestamp":1219795200000},"content-version":"vor","delay-in-days":3070,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,4]]},"abstract":"<jats:p>Inhibitor formation in patients with haemophilia receiving factor VIII (FVIII) concentrate is a common problem requiring tolerance induction therapy. Immune tolerance is dependent on defective T cell\/antigen\u2010presenting cell (APC) interactions and inhibitor antibody formation is associated with effective T\u2010cell\/B\u2010cell interaction. We studied the expression of the cell\u2010surface molecules involved with these interactions using multiparameter flow cytometry and a whole blood stimulation assay\u2013phytohaemaglutinin (PHA) to activate T cells and <jats:italic>Escherichia coli<\/jats:italic> lipopolysaccharide (LPS) to activate monocytes and B cells. Up\u2010regulation of T\u2010cell co\u2010stimulatory receptors CD11a, CD40 ligand (CD40L) and CTLA4 were inhibited in a dose\u2010dependent manner by plasma\u2010derived (pd)FVIII, but CD28 was unchanged. Up\u2010regulation of monocyte and B\u2010cell co\u2010stimulatory ligands CD4O, B7\u20101 (CD80) and B7\u20102 (CD86) were also inhibited in a dose\u2010dependent manner by pdFVIII, but LFA\u20103 (CD58) was unchanged. The combined inhibitory effect of prednisolone, an immunosuppressive agent used in several tolerance induction protocols, with pdFVIII on co\u2010stimulatory molecules, was additive. There was no significant alteration in T\u2010cell\/APC adhesion or co\u2010stimulatory molecules noted in the presence of recombinant (rh)FVIII concentrate. The inhibitory effect of pdFVIII on molecules involved in interaction between T cells and APCs may result in immune tolerance in recipients of pdFVIII concentrate. The inhibitory effect of pdFVIII on CD40\/CD40L up\u2010regulation may result in defective antibody formation. We now provide evidence that the use of pdFVIII, through interfering with APC\/T\u2010cell interactions, may be more appropriate than rhFVIII for tolerance induction.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.01994.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:23:09Z","timestamp":1047363789000},"page":"195-200","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of factor VIII concentrate on antigen\u2010presenting cell (APC)\/T\u2010cell interactions <i>in vitro<\/i>: relevance to inhibitor formation and tolerance induction"],"prefix":"10.1111","volume":"109","author":[{"given":"G.","family":"Hodge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,8,27]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.155.9.4397","article-title":"Differential regulation of transforming growth factor beta\u20101 gene expression by glucocorticoids in human T and glial cells","volume":"155","author":"Batuman O.A.","year":"1995","journal-title":"Journal of Immunology"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(92)90138-W"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90188-Q"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.4.915"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.440568.x"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.4049\/jimmunol.151.3.1224","article-title":"IL\u201010 inhibits macrophage costimulatory activity by selectively inhibiting the upregulation of B7 expression","volume":"151","author":"Ding L.","year":"1993","journal-title":"Journal of Immunology"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.1.157"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.591"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1182\/blood.V87.11.4887.bloodjournal87114887","article-title":"Complete blockage of B7 family\u2010mediated costimulation is necessary to induce human alloantigen\u2010specific anergy: a method to ameliorate graft versus host disease and extend the donor pool","volume":"11","author":"Gribben J.G.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.1.19"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.10.3261.3261"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1997.tb48623.x"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb08409.x"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01601.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01385.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1999.00538.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.4049\/jimmunol.160.4.1589","article-title":"TGF\u2010beta promotes immune deviation by altering accessory signals of antigen\u2010presenting cells","volume":"160","author":"Takeguchi M.","year":"1998","journal-title":"Journal of Immunology"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1997.00319.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.3.393"},{"key":"e_1_2_5_21_2","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1182\/blood.V84.6.2021.2021","article-title":"Identification of transforming growth factor\u2010\u03b2 as a contaminant in factor V111 concentrates. A possible link with immunosuppressive effects in haemophiliacs","volume":"84","author":"Wadhwa M.","year":"1994","journal-title":"Blood"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01994.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.01994.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.01994.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T07:07:43Z","timestamp":1695884863000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.01994.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1046\/j.1365-2141.2000.01994.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.01994.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]},"assertion":[{"value":"2008-08-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}